期刊文献+

原发性膀胱腺癌临床及病理分析 被引量:1

下载PDF
导出
摘要 目的探讨原发性膀胱腺癌的临床病理特征。方法回顾性分析浙江省余姚市人民医院2014年1月-2019年12月收治的4例原发性膀胱腺癌的临床资料及相关病理特征。结果肿瘤发生于膀胱后壁2例,右侧壁1例,膀胱颈口1例。巨检菜花状肿物2例,黏膜增厚1例,黏膜僵硬1例。镜下肿瘤呈腺管状、印戒样排列,浸润性生长,其中中分化癌1例,中-低分化癌3例,中低分化癌中合并前列腺微小癌及印戒细胞癌各1例。免疫组化:3例CK7(+);2例CK20(+),其中1例局灶(+);CEA(+)4例;1例CDX2局灶(+)。结论原发性膀胱腺癌发病率低,需要与膀胱转移性腺癌及尿路上皮癌进行鉴别,免疫组化表现为CK7(+)、CK20(+)、CDX2(+),对鉴别诊断有重要意义。该疾病恶性程度高,容易复发且预后差,早期诊断、彻底的手术治疗是首选。
机构地区 余姚市人民医院
出处 《浙江实用医学》 2020年第4期288-290,共3页 Zhejiang Practical Medicine
  • 相关文献

参考文献3

二级参考文献25

  • 1Gill HS, Dhillon IlK, Woodhouse CR, et al. Adenocarcinoma of the urinary bladder[J]. Br J Urol, 1989,64(2) : 138 - 142.
  • 2AnderstriJm C, Johansson SL, yon Schultz L, et al. Primary adeno- carcinoma of the urinary bladder. A clinicopathologie and prognostic study[J]. Cancer,1983,52(7) :1273 - 1280.
  • 3Terada T. Primary pure signet - ring cell adenocarcinomaof the uri- nary bladder:a report of three cases with an immunohistochemical study[ J]. Med Oncol,2012,29(4) :2866 -2869.
  • 4Kato M, Onishi T, Hoshina A, et al. Successful treatment with pacli- taxeL/carboplatin chemotherapy in advanced adenocarcinoma of the urinary tract producing earcinoembryonic antigen, carbohydrate an- tigen 19 - 9 and carbohydrate antigen 125 [ J ]. Urol Int,2010,84 (1):116-118.
  • 5Marino G, Motta E, Mosso L, et al. Primary signet ring cell adeno- carcinoma of the bladder[ J ]. Minerva Urol Nefrol, 2005,57 ( 2 ) : 125 - 127.
  • 6Romero Otero J, Duarte Ojeda JM, Cruceyra Betriu G, et al. Primary adenocarcinoma of the urinary bladder:our experience [ J ]. Actas Urol Esp ,2005,29 ( 3 ) :257 - 260.
  • 7Kawamura N, Matsushita M, Okada T, et al. Relative efficacy of neoadjuvant gemcitabine and cisplatin versus methotrexate, vinblas- tine, adriamycin, and cisplatin in the management for muscle - in- vasive bladder cancer [J]. Hinyokika Kiyo,2013,59(5) :277 - 281.
  • 8Logothetis C J, Samuels ML, Ogden S, et al. Chemotherapy for ade- nocarcinomas of bladder and urachal origin : 5 - fluorouracil, doxo- rubicin, and mitomycin - C [ J ]. Urology, 1985,26 ( 3 ) :252 - 255.
  • 9Tsuji W, Ishiguro H, Tanaka S, et al. Orally administered S - 1 sup- presses circulating endothelial cell counts in metastatic breast canc- er patients[ J]. Int J Clin Oncol,2014,19:452 - 459.
  • 10Sanford M. S -1 (Teysuno)) :A review of Its use in advanced gastric cancer in non -asian populations[J]. Drugs,2013,73:845.

共引文献6

同被引文献6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部